The Claim
In older adults with preclinical Alzheimer’s disease, baseline tau PET burden in the entorhinal cortex is more strongly associated with future cognitive decline than tau PET burden in any other brain region or plasma p-tau217 levels, with a correlation coefficient of −0.55.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults showing early signs of Alzheimer’s disease before symptoms appear, higher levels of tau protein in the entorhinal cortex measured by PET scan are consistently linked to greater future decline in memory and thinking skills, more so than tau in other brain areas or tau levels in the blood.
See the scientific wording
In older adults with preclinical Alzheimer’s disease, baseline tau PET burden in the entorhinal cortex is more strongly associated with future cognitive decline than any other brain region or plasma p-tau217, with a correlation coefficient of −0.55, suggesting it is a key early site of pathology that predicts long-term cognitive outcomes.
Tau proteins build up first in the memory hub of the brain, which weakens connections to nearby regions that store and retrieve memories. This damage spreads over time, causing memory loss that gets worse as more brain areas fail.
What the research says
1 studyStudy: Concurrent changes in plasma p-tau217, tau PET, and cognition in preclinical Alzheimer’s disease
In older adults with early Alzheimer’s changes, a brain scan showing tau buildup in the memory-related entorhinal cortex is a better predictor of future memory loss than a blood test for tau, making it a key early warning sign.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.